Postpartum pelvic floor disorders are estimated to impact 24% of women in the United States. This study describes the use of a radiofrequency device (Votiva, InMode) for postpartum pelvic floor restoration using an electrostimulator to objectively measure treatment effect.  A retrospective evaluation was conducted between April 2017 and May 2018 of consecutive patients undergoing vaginal radiofrequency treatment. Inclusion criteria were patients at least 6 weeks postvaginal delivery with symptoms of pelvic floor dysfunction. Resting pelvic floor muscle tone and maximal pelvic floor contraction were measured. DOWNLOAD PAPER

Vaginal laxity and atrophy are caused mainly by aging and vaginal childbirth, which lead to a loss of strength and flexibility within the vaginal wall. As a result, women may experience vaginal, pelvic, sexual and urinary symptoms that significantly affect their quality of life. the aim of this study was to evaluate the safety and efficacy of a novel radiofrequency (RF) device for internal and external vaginal treatment. DOWNLOAD PAPER

- In the past 5 to 10 years, a surge of interest in female intimate wellness, specifically vaginal rejuvenation, both surgical and nonsurgical, has been witnessed. - For both cosmetic and functional reasons, increasing numbers of women have sought alternatives to traditional therapies for dealing with the common but unwelcome changes that occur to the vaginal and vulvar tissues induced by maternity, weight fluctuation, hormonal change (sometimes following cancer care), natural aging, and menopause. - Traditional nonsurgical options of improving vaginal well-being for the premenopausal as well as postmenopausal woman have proven to have limited long-term benefit, and therefore, patient compliance with these methods can be poor. DOWNLOAD PAPER